Abstract PS2-08-01: A predictive gene signature for benefit from dose-dense adjuvant chemotherapy in patients with high-risk early breast cancer: results from the PANTHER phase III trial
Year: 2026
Type: conference-abstract
Source: Clinical Cancer Research
Authors: D. Salgkamis, M. Sarafidis, E. Sifakis, I. Zerdes, S. Agartz, J. Hartman, M. Hellström, T. Foukakis, J. Bergh, A. Matikas
Institution: Karolinska Institutet
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7130721751
Cites:
Cited by:
Related to: